A Kelly Michael - Net Worth and Insider Trading

A Kelly Michael Net Worth

The estimated net worth of A Kelly Michael is at least $11 Million dollars as of 2024-12-28. A Kelly Michael is the Acting CFO of Amgen Inc and owns about 41,224 shares of Amgen Inc (AMGN) stock worth over $11 Million. Details can be seen in A Kelly Michael's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that A Kelly Michael has not made any transactions after 2014-04-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of A Kelly Michael

A Kelly Michael Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, A Kelly Michael owns 1 companies in total, including Amgen Inc (AMGN) .

Click here to see the complete history of A Kelly Michael’s form 4 insider trades.

Insider Ownership Summary of A Kelly Michael

Ticker	Comapny	Transaction Date	Type of Owner
AMGN	Amgen Inc	2014-04-28	VP Finance & CAO

A Kelly Michael Latest Holdings Summary

A Kelly Michael currently owns a total of 1 stock. A Kelly Michael owns 41,224 shares of Amgen Inc (AMGN) as of April 28, 2014, with a value of $11 Million.

Latest Holdings of A Kelly Michael

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AMGN	Amgen Inc	2014-04-28	41,224	262.65	10,827,484

Holding Weightings of A Kelly Michael

A Kelly Michael Form 4 Trading Tracker

According to the SEC Form 4 filings, A Kelly Michael has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 2,065 shares on April 28, 2014, which brought A Kelly Michael around $228,079.

Insider Trading History of A Kelly Michael

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

A Kelly Michael Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

A Kelly Michael Ownership Network

Ownership Network List of A Kelly Michael

No Data

Ownership Network Relation of A Kelly Michael

A Kelly Michael Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

A Kelly Michael is the VP Finance & CAO of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, A Kelly Michael made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 4,213 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,771 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,771 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amgen Inc Insider Transactions

No Available Data

A Kelly Michael Mailing Address

Above is the net worth, insider trading, and ownership report for A Kelly Michael. You might contact A Kelly Michael via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Discussions on A Kelly Michael

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.